News

2014 Nov 06

Chen-Kiang honored with $600k V Foundation translational grant

Selina Chen-Kiang, Ph.D., was among 12 scientists selected from across the nation to receive a $600,000 award to promote translational cancer research. Read more

2014 Nov 05

Roboz discusses progress, challenges in AML

Gail J. Roboz, M.D., discusses the status of research into acute myeloid leukemia during a presentation at the 2014 Chemotherapy Foundation Symposium. Read more

2014 Oct 20

Cantley elected to the Institute of Medicine of the National Academies

Meyer Cancer Center Director Lewis C. Cantley receives one of the highest honors in the fields of health and medicine Read more

2014 Oct 07

Cancer research breakthrough for WCMC-Qatar

Researchers at Weill Cornell Medical College in Qatar have made a major step towards understanding why certain cancers often recur after they have been treated with conventional therapies. Read more

2014 Oct 02

Liquid biopsy project receives innovation award and funding

David Lyden’s blood test to isolate cancer released exosomes was one of six projects selected as winners of the inaugural Daedalus Fund for Innovation. Read more

2014 Sep 22

Target Practice: Precision approaches are a major advance in the treatment of blood cancers

A feature in Weill Cornell Medicine highlights some of the work being done by John Leonard, Leandro Cerchietti, Ari Melnick and others at the Meyer Cancer Center to tailor treatments to individual patients. Read more

2014 Sep 10

End-of-life care preferences: A promising target for reducing racial disparities in terminal cancer care

Race and ethnicity dramatically influence patients' end-of-life preferences, which affect the likelihood they will complete a do-not-resuscitate order. Read more

2014 Sep 04

The newest precision medicine tool: Prostate cancer organoids

Work by Andrea Shoner and his team has demonstrated that organ tissue derived from human prostate cancer tumors can be grown in the laboratory, giving researchers a new tool to test cancer drugs and personalize cancer treatment. Read more

2014 Sep 02

Donors support recruitment of star researcher

“Once-in-a-generation” researcher John Blenis joins the Meyer Cancer Center team as Anna-Maria and Stephen Kellen Professor of Cancer Research. Read more

2014 Jul 31

Researchers see promise for two new therapies for mantle cell lymphoma

A research team led by Selina Chen-Kiang has revealed key insights into why late resistance to breakthrough drug ibrutinib occurs in many mantle cell lymphoma patients, and has shown preclinical success with two new treatment strategies. Read more

2014 Jun 11

Preventing tongue cancer with a drug combination

Researchers at Weill Cornell Medical College have discovered what they believe may be the first effective drug therapy to prevent tongue cancer, one of the world's most common cancers. Read more

2014 Jun 01

Bench to Bedside

The Cornell Alumni Magazine features director Lewis Cantley and several other Meyer Cancer Center leaders. Read more

2014 May 12

Paying it forward: Breakthrough Prize winners support next generation of scientists

Meyer Cancer Center director Lewis Cantley has collaborated with fellow Breakthrough Prize award winners to establish a new annual life sciences award for postdocs. Read more

2014 Jan 08

$75M gift creates Meyer Cancer Center at Weill Cornell

A $75 million gift from Sandra and Edward Meyer ’48 and the Sandra and Edward Meyer Foundation will enhance the medical college’s distinguished cancer research and care programs. Read more

2001 Aug 22

The cancer drug that almost wasn't

Feature in Science highlights Selina Chen-Kiang’s dogged determination in her quest to resurrect the drug palbociclib for its potential in treating blood cancers. Read more

News

Chen-Kiang honored with $600k V Foundation translational grant

Roboz discusses progress, challenges in AML

Cantley elected to the Institute of Medicine of the National Academies

Cancer research breakthrough for WCMC-Qatar

Liquid biopsy project receives innovation award and funding

Target Practice: Precision approaches are a major advance in the treatment of blood cancers

End-of-life care preferences: A promising target for reducing racial disparities in terminal cancer care

The newest precision medicine tool: Prostate cancer organoids

Donors support recruitment of star researcher

Researchers see promise for two new therapies for mantle cell lymphoma

Preventing tongue cancer with a drug combination

Bench to Bedside

Paying it forward: Breakthrough Prize winners support next generation of scientists

$75M gift creates Meyer Cancer Center at Weill Cornell

The cancer drug that almost wasn't

Follow us on X

2022 Annual Report

2021 Annual Report

2018 Annual Report

2017 Annual Report

2016 Annual Report

Newsletters